LOS ANGELES - A surprising new study found that the controversial drug hydroxychloroquine was associated with a significant reduction in mortality among sick patients hospitalized with COVID-19.A team at Henry Ford Health System in Detroit, Michigan studied 2,541 patients hospitalized with a COVID-related admission between March 10 to May 2.“Our analysis shows that using hydroxychloroquine helped saves lives,” said neurosurgeon Dr.
Steven Kalkanis, CEO, Henry Ford Medical Group and Senior Vice President and Chief Academic Officer of Henry Ford Health System.“As doctors and scientists, we look to the data for insight.